Usefulness of uric acid to predict changes in c-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years

被引:120
作者
Ruggiero, Carmelinda
Cherubini, Antonio
Miller, Edgar, III
Maggio, Marcello
Najjar, Sarner S.
Lauretani, Fulvio
Bandinelli, Stefania
Senin, Umberto
Ferrucci, Luigi [1 ]
机构
[1] NIA, Longitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA
[2] NIA, Human Cardiovasc Studies Unit, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA
[3] Univ Perugia, Sch Med, Dept Clin & Expt Med, Inst Gerontol & Geriatr, I-06100 Perugia, Italy
[4] Tuscany Reg Hlth Agcy, Florence, Italy
[5] ASF Geriatr Rehabil, Florence, Italy
关键词
D O I
10.1016/j.amjcard.2007.02.065
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The role of uric acid (UA) in the process of atherothrombosis is controversial. Although serum UA has powerful antioxidant properties, epidemiological studies showed that UA was a risk factor for cardiovascular diseases and was positively associated with proinflammatory markers. Relations between baseline UA and changes in UA circulating levels with C-reactive protein (CRP) and interleukin-6 (IL-6) after 3 years of follow-up in a cohort of 892 Italian men and women aged 21 to 98 years was investigated. Subjects had complete baseline and follow-up data for UA, inflammatory markers, and covariates. An autoregressive approach was used to study such a relation. In adjusted analyses, baseline UA and changes in UA predicted a 3-year change in CRP (p = 0.028), but not IL-6 (p = 0.101). The relation between UA and CRP persisted after adjustment for baseline IL-6. Subjects with high UA at baseline had a progressively higher probability of developing clinically relevant increased IL-6 (>2.5 pg/ml) and CRP (>3 mg/L) during 3 years. In conclusion, our study suggests that in a population-based cohort, baseline UA and changes in circulating UA during 3 years of follow-up predict changes in circulating CRP independent of relevant confounders, including baseline IL-6. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 30 条
[1]
Uric acid and cardiovascular risk [J].
Alderman, MH .
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (02) :126-130
[2]
Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging [J].
Anker, SD ;
Doehner, W ;
Rauchhaus, M ;
Sharma, R ;
Francis, D ;
Knosalla, C ;
Davos, CH ;
Cicoira, M ;
Shamim, W ;
Kemp, M ;
Segal, R ;
Osterziel, KJ ;
Leyva, F ;
Hetzer, R ;
Ponikowski, P ;
Coats, AJS .
CIRCULATION, 2003, 107 (15) :1991-1997
[3]
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? [J].
Baker, JF ;
Krishnan, E ;
Chen, L ;
Schumacher, HR .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (08) :816-826
[4]
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies [J].
Doehner, W ;
Schoene, N ;
Rauchhaus, M ;
Leyva-Leon, F ;
Pavitt, DV ;
Reaveley, DA ;
Schuler, G ;
Coats, AJS ;
Anker, SD ;
Hambrecht, R .
CIRCULATION, 2002, 105 (22) :2619-2624
[5]
Sevum uric acid and cardiovascular mortality - The NHANES I epidemiologic follow-up study, 1971-1992 [J].
Fang, J ;
Alderman, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2404-2410
[6]
Allopurinol improves endothelial dysfunction in chronic heart failure [J].
Farquharson, CA ;
Butler, R ;
Hill, A ;
Belch, JJF ;
Struthers, AD .
CIRCULATION, 2002, 106 (02) :221-226
[7]
Hyperuricemia in childhood primary hypertension [J].
Feig, DI ;
Johnson, RJ .
HYPERTENSION, 2003, 42 (03) :247-252
[8]
Serum IL-6 level and the development of disability in older persons [J].
Ferrucci, L ;
Harris, TB ;
Guralnik, JM ;
Tracy, RP ;
Corti, MC ;
Cohen, HJ ;
Penninx, B ;
Pahor, M ;
Wallace, R ;
Havlik, RJ .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (06) :639-646
[9]
Subsystems contributing to the decline in ability to walk: Bridging the gap between epidemiology and geriatric practice in the InCHIANTI study [J].
Ferrucci, L ;
Bandinelli, S ;
Benvenuti, E ;
Di Iorio, A ;
Macchi, C ;
Harris, TB ;
Guralnik, JM .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (12) :1618-1625
[10]
Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP) [J].
Franse, LV ;
Pahor, M ;
Di Bari, M ;
Shorr, RI ;
Wan, JY ;
Somes, GW ;
Applegate, WB .
JOURNAL OF HYPERTENSION, 2000, 18 (08) :1149-1154